Mouse models of human breast cancer: evolution or convolution?
By J. Green. Breast Cancer Research, 2003
616 citations recorded by the source corpus.
Our goal is to evaluate the use of ultrasound to detect small regions of increased vascular density and altered blood flow and to quantify small changes in these parameters due to effects of new anti-angiogenic drugs. Regions containing intravascular contrast agents are identified using a new ultrasound strategy that combines subharmonic and phase inversion imaging. The contrast agent is repeatedly destroyed in order to estimate the time required for local replenishment. Parameters are estimated based on this strategy and include measures of the spatial extent of flow, the spatial integral of flow, and the time required for 80% replenishment. In a study of 25 tumors, we first demonstrate that regions of viable tumor as small as 1 mm, as verified by histology, can be detected and show similar morphology to images acquired with computed tomography (CT). The spatial mapping of vessels with ultrasound is superior to contrast enhanced computed tomography due to the intravascular distribution of ultrasound contrast agents. Estimation of the time to 80% replenishment was conducted on kidney and tumor data and is a robust parameter not altered by attenuation. Mean times to 80% replenishment of 1–5 s were estimated for the kidney cortex and mean times of 6–14 s were observed for viable tumor tissue. This broad range of replenishment times is indicative of abnormal tumor vascular density and tortuosity. Changes in flow parameters with anti-angiogenic therapy are significant beginning at 48 hours post-treatment.
Subfields: Biotechnology, Genetics, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/2e41f8b0ecdcdf35f12e0c30f1f7de9539220264
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biotechnology
In Genetics
In Radiology, Nuclear Medicine and Imaging
Citations in the corpus
- Stem cell origin of cancer and differentiation therapy. (2004, background): “If the malignant cells of cancers are cancer stem cells [6,180,233,239–241], then it should be possible to treat cancers by inducing differentiation of the stem cells, i.”
- Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells (2004, background): “We have postulated that the tumor stem cell population drives tumorigenesis, recurrence and metastasis [ 40 ].”